3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells

被引:126
作者
Yohe, Stefan T. [2 ,3 ]
Herrera, Victoria L. M. [4 ]
Colson, Yolonda L. [1 ]
Grinstaff, Mark W. [2 ,3 ]
机构
[1] Brigham & Womens Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02215 USA
[2] Brigham & Womens Hosp, Dept Biomed Engn, Boston, MA 02215 USA
[3] Brigham & Womens Hosp, Dept Chem, Boston, MA 02215 USA
[4] Boston Univ, Sch Med, Dept Cardiol, Boston, MA 02215 USA
关键词
Superhydrophobic; Biomaterial; Local drug delivery; Electrospinning; Colorectal cancer; Recurrence; PHARMACOKINETIC TRIAL; POLYMER IMPLANTS; COLON-CANCER; PHASE-I; CAMPTOTHECIN; CHEMOTHERAPY; SCAFFOLDS; SURFACES; SYSTEMS; CPT-11;
D O I
10.1016/j.jconrel.2012.05.047
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this work we expand upon a recently reported local drug delivery device, where air is used as a degradable component of our material to control drug release (J. Am. Chem. Soc. 2012, 134, 2016-2019). We consider its potential use as a drug loaded strip to provide both mechanical stability to the anastomosis, and as a means to release drug locally over prolonged periods for prevention of locoregional recurrence in colorectal cancer. Specifically, we electrospun poly(epsilon-caprolactone) (PCL) with the hydrophobic polymer dopant poly(glycerol monostearate-co-epsilon-caprolactone) (PGC-C18) and used the resultant mesh to control the release of two anticancer drugs (CPT-11 and SN-38). The increase in mesh hydrophobicity with PGC-C18 addition slows drug release both by the traditional means of drug diffusion, as well as by increasing the stability of the entrapped air layer to delay drug release. We demonstrate that superhydrophobic meshes have mechanical properties appropriate for surgical buttressing of the anastomosis, permit non-invasive assessment of mesh location and documentation of drug release via ultrasound, and release chemotherapy over a prolonged period of time (>90 days) resulting in significant tumor cytotoxicity against a human colorectal cell line (HT-29). (C) 2012 Elsevier B. V. All rights reserved.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 49 条
  • [1] [Anonymous], ADV MAT
  • [2] [Anonymous], WORLD J GASTROENTERO
  • [3] [Anonymous], OBES SURG
  • [4] American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
    Benson, AB
    Schrag, D
    Somerfield, MR
    Cohen, AM
    Figueredo, AT
    Flynn, PJ
    Krzyzanowska, MK
    Maroun, J
    McAllister, P
    Van Cutsem, E
    Brouwers, M
    Charette, M
    Haller, DG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3408 - 3419
  • [5] POLYMERS TO TREAT BRAIN-TUMORS
    BREM, H
    [J]. BIOMATERIALS, 1990, 11 (09) : 699 - 701
  • [6] ETHYL SUBSTITUTION AT THE 7-POSITION EXTENDS THE HALF-LIFE OF 10-HYDROXYCAMPTOTHECIN IN THE PRESENCE OF HUMAN SERUM-ALBUMIN
    BURKE, TG
    MI, Z
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (17) : 2580 - 2582
  • [7] Nanoparticle therapeutics: an emerging treatment modality for cancer
    Davis, Mark E.
    Chen, Zhuo
    Shin, Dong M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) : 771 - 782
  • [8] Polymeric drug delivery systems for localized cancer chemotherapy
    De Souza, Raquel
    Zahedi, Payam
    Allen, Christine J.
    Piquette-Miller, Micheline
    [J]. DRUG DELIVERY, 2010, 17 (06) : 365 - 375
  • [9] Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro
    EricksonMiller, CL
    May, RD
    Tomaszewski, J
    Osborn, B
    Murphy, MJ
    Page, JG
    Parchment, RE
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (05) : 467 - 472
  • [10] Drug-eluting polymer implants in cancer therapy
    Exner, Agata A.
    Saidel, Gerald M.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (07) : 775 - 788